Albemarle (NYSE:ALB) Trading Down 4.1% – Here’s What Happened

30 Jun 2025, 13:02 by Renee Jackson · The Cerbat Gem

Albemarle Corporation (NYSE:ALB – Get Free Report)’s stock price was down 4.1% on Monday . The stock traded as low as $62.50 and last traded at $62.28. Approximately 385,650 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 2,841,125 shares. The stock had previously closed at $64.95.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ALB shares. TD Securities dropped their price target on Albemarle from $115.00 to $65.00 and set a “hold” rating for the company in a research report on Thursday, May 1st. Scotiabank dropped their target price on shares of Albemarle from $75.00 to $65.00 and set a “sector perform” rating for the company in a research report on Tuesday, May 6th. Wells Fargo & Company cut their price target on shares of Albemarle from $80.00 to $60.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 9th. Citigroup lowered their price objective on shares of Albemarle from $85.00 to $64.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 15th. Finally, Wall Street Zen upgraded shares of Albemarle to a “sell” rating in a research report on Monday, May 5th. Three research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Albemarle presently has an average rating of “Hold” and an average price target of $91.62.

Get Our Latest Stock Analysis on Albemarle

Albemarle Trading Down 2.9%

The stock’s 50-day simple moving average is $59.08 and its 200-day simple moving average is $72.05. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.26 and a current ratio of 2.11. The firm has a market capitalization of $7.42 billion, a PE ratio of -5.68 and a beta of 1.61.

Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.62) by $0.44. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.18 billion. Albemarle had a negative return on equity of 1.92% and a negative net margin of 22.39%. The firm’s revenue for the quarter was down 20.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.26 earnings per share. As a group, sell-side analysts expect that Albemarle Corporation will post -0.04 EPS for the current fiscal year.

Albemarle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Friday, June 13th will be issued a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date is Friday, June 13th. Albemarle’s dividend payout ratio (DPR) is presently -14.57%.

Hedge Funds Weigh In On Albemarle

Several large investors have recently made changes to their positions in ALB. Metis Global Partners LLC grew its stake in shares of Albemarle by 3.9% in the 4th quarter. Metis Global Partners LLC now owns 3,908 shares of the specialty chemicals company’s stock worth $336,000 after buying an additional 148 shares during the last quarter. SlateStone Wealth LLC grew its stake in shares of Albemarle by 3.3% in the fourth quarter. SlateStone Wealth LLC now owns 4,655 shares of the specialty chemicals company’s stock worth $401,000 after acquiring an additional 150 shares during the last quarter. Toronto Dominion Bank increased its holdings in shares of Albemarle by 0.4% during the fourth quarter. Toronto Dominion Bank now owns 39,657 shares of the specialty chemicals company’s stock valued at $3,414,000 after acquiring an additional 158 shares in the last quarter. Lindbrook Capital LLC raised its position in shares of Albemarle by 34.0% in the 4th quarter. Lindbrook Capital LLC now owns 626 shares of the specialty chemicals company’s stock worth $54,000 after purchasing an additional 159 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its position in shares of Albemarle by 62.4% in the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the specialty chemicals company’s stock worth $41,000 after purchasing an additional 181 shares during the last quarter. 92.87% of the stock is currently owned by hedge funds and other institutional investors.

Albemarle Company Profile

(Get Free Report)